The Uncertain Path Forward for Psychedelic Medicine

After the FDA rejected its proposed MDMA treatment, Lykos Therapeutics is laying off 75 percent of its staff and its founder has left the company.

from Wired https://ift.tt/jQu1CxT

Comments

Popular posts from this blog

Tableau launches new enterprise plans, big data tools

Galaxy Book 3 leak spills the beans on the latest Samsung laptops